Previous 10 | Next 10 |
2024-04-21 14:42:04 ET More on the markets SPY: Higher For Longer Could Be Good News S&P 500: Positive Outlook, I'm Modifying My Hedge SPY: Resurgent Inflation, Soaring Yields, Geopolitical Turmoil - 1970s All Over Again? Wall Street's April pullback inte...
2024-04-21 10:49:18 ET Summary The yield on the 10-Year Treasury has risen to 4.62% from under 3.9% in late February. Rising rates are taking an increasing toll on the market, as the S&P 500 posted its worst weekly performance since March of 2023 this week. Bubbles in the ...
2024-04-21 09:36:07 ET Summary A list of high-quality dividend growth stocks trading near 52-week lows is evaluated based on Historical and Future Fair values. Apple appears to be near fair value, and trading near 52-week lows could be at a favorable entry point for long-term inve...
2024-04-20 12:03:00 ET Summary abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield of 11.3% and exposure to diverse subsectors of the healthcare industry. The fund outperforms its peers, abrdn World Healthcare Fund (THW) and BlackRock's Health Sciences Trust (BM...
2024-04-19 15:00:19 ET More on the markets S&P 500: Positive Outlook, I'm Modifying My Hedge SPY: Resurgent Inflation, Soaring Yields, Geopolitical Turmoil - 1970s All Over Again? SPY: Sell Signals Caused By War Uncertainty (Technical Analysis Downgrade) ...
2024-04-19 07:03:48 ET Summary Since my last article, the company's share price has fallen about 10% despite its quarterly revenue growth and achieving significant success in developing experimental drugs. In addition to growing sales of next-generation drugs such as Ngenla, Bosul...
2024-04-18 18:00:00 ET Summary Today, I will present you with two attractive high dividend yield companies that can help to enhance your dividend income. I have added both companies to The Dividend Income Accelerator Portfolio. This is due to their strong alignment with the portfo...
2024-04-18 13:59:29 ET Summary Caribou Biosciences, Inc. is expected to produce results from phase 1 ANTLER study, using CB-010 for the treatment of 2nd-line large B-cell lymphoma patients, at medical meeting Q2 of 2024. Initial dose escalation data from the phase 1 ANTLER study i...
A look at the top 10 most actives in Canada Troilus Gold Corp (TLG) rose 1.4% to $0.7 on volume of 19,342,615 shares Royal Bank of Canada (RY) fell 0.1% to $133.2 on volume of 3,932,729 shares Desjardins RI Developed ex-USA ex-Canada - Low CO2 Index ETF (DRMD) rose 0.0% to $26.72 on volum...
2024-04-18 09:15:00 ET If you had bought $1,000 worth of Pfizer (NYSE: PFE) shares five years ago, how much would that be worth today? The answer will strike you as terrific or terrible: $840. That answer will be terrible if you did buy into Pfizer then as it reflects a loss...
News, Short Squeeze, Breakout and More Instantly...
2024-05-05 06:55:00 ET Don't believe the adage to "sell in May and go away." Buying stocks can still be a smart move, especially if you're a long-term investor. Three Motley Fool contributors have identified stocks they think are no-brainers to buy in May. Here's why they picked Eli L...
2024-05-04 06:45:00 ET Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk . Both stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more than quadrupling and Novo's shares more than tripling over the last three ye...
Pfizer Inc (NYSE:PFE) reported first-quarter earnings Wednesday with adjusted EPS of 82 cents. That’s down 33% year-over-year, beating the ...